Page 32 - Johnson Medtech News Today

For World Stroke Day 2022, News-Medical speaks to Dr. Patrick Brouwer, Head of Worldwide Medical Affairs at CERENOVUS, about why saving #Precioustime is critical when it comes to recognizing and seeking medical treatment for stroke.

Johnson & Johnson's Ashley McEvoy and Abiomed's Michael Minogue discussed the biggest trends they see in medtech right now.

Health news and commentary from around the Web gathered by <em>MedPage Today</em> staff

/PRNewswire/ -- Today, Johnson & Johnson MedTech* announced that DePuy Synthes, The Orthopaedics Company of Johnson & Johnson**, has secured 510(k) clearance...

Johnson & Johnson MedTech's DePuy Synthes received FDA 510(k) clearance for its Teligen technology platform for spinal procedures.

In line with its commitment to raise awareness of cardiovascular disease and conditions in the Kingdom, Johnson & Johnson MedTech participated in the 33rd Annual Conference of Saudi Heart Association, one of the largest cardiac meetings in the Middle East that was held in Riyadh from Oct. 13 -15. The company unveiled its “Get Smart About AFib” global campaign at the conference

Biosense Webster, Inc., part of Johnson & Johnson MedTech, today announced the European launch of the HELIOSTAR™ Balloon Ablation Catheter.

The HELIOSTAR Balloon Ablation Catheter's unique one-shot balloon technology enables pulmonary vein isolation in 12 seconds, with customized energy delivery and one integrated 3D mapping solution 

/PRNewswire/ -- Biosense Webster, Inc., part of Johnson & Johnson MedTech†, today announced the European launch of the HELIOSTAR™ Balloon Ablation Catheter –...

The TECNIS PC-IOL Portfolio Powered by InteliLight delivers the best* contrast and low-light performance across the PC-IOL category1,2,3TECNIS Sym...